Showing results (41-50 of 147) with videos related to
Sort By:
Pageof 15
Australian and New Zealand Journal of Medicine|February 1, 1991
Inability to detect circulating anti-idiotypic antibodies in human anti-GBM antibody-mediated disease using a splenic PFC assayJ A Savige, C M LockwoodAdvances in Internal Medicine|January 1, 1990
Autoantibodies in primary systemic vasculitisC O Savage, C M LockwoodEuropean Journal of Immunology|May 1, 1984
Autoregulation of autoantibody synthesis in mercuric chloride nephritis in the Brown Norway rat. II. Presence of antigen-augmentable plaque-forming cells in the spleen is associated with humoral factors behaving as auto-anti-idiotypic antibodiesJ M Chalopin, C M LockwoodClinical and Experimental Immunology|November 21, 1997
Studies of epitope restriction on myeloperoxidase (MPO), an important antigen in systemic vasculitisA K Short, C M LockwoodThe British Journal of Dermatology|February 1, 1995
Antineutrophil cytoplasmic antibodies and their relevance to the dermatologistN P Burrows, C M LockwoodClinical and Experimental Immunology|March 1, 1996
Azurocidin is a novel antigen for anti-neutrophil cytoplasmic autoantibodies (ANCA) in systemic vasculitisM H Zhao, C M LockwoodJournal of Immunological Methods|October 16, 1996
A comprehensive method to purify three major ANCA antigens: proteinase 3, myeloperoxidase and bactericidal/permeability-increasing protein from human neutrophil granule acid extractM H Zhao, C M LockwoodClinical and Experimental Immunology|August 1, 1987
Restriction of human IgG subclass expression in the population of auto-antibodies to glomerular basement membraneC Bowman, K Ambrus, C M LockwoodLupus|April 24, 2001
Treatment of systemic lupus erythematosus with mycophenolate mofetilD Adu, J Cross, D R JayneQJM : Monthly Journal of the Association of Physicians|December 1, 1994
Endothelial cell activation in patients with systemic vasculitisJ R Bradley, C M Lockwood, S ThiruPageof 15